Back to Immunoglobulin A Nephropathy

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

    ACTIVE NOT RECRUITING → COMPLETED

    Recorded 2026-10-14

    View record
  2. A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy

    RECRUITING → ACTIVE NOT RECRUITING

    Recorded 2026-10-14

    View record